NCT00348348View on ClinicalTrials.gov

A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL

Enrollment

1,161

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Acute Bacterial Conjunctivitis

Interventions

DRUG

Besifloxacin

Besifloxacin hydrochloride ophthalmic suspension, 0.6% as base, administered TID for 5 days

DRUG

Moxifloxacin solution

Moxifloxacin hydrochloride ophthalmic solution 0.5% administered TID for 5 days.

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00348348 - A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis | Biotech Hunter | Biotech Hunter